Consequences of Sexual Violence Among Women Living in Democratic Republic of Congo
SV-RDC
Perineal, Psychological and Well-beeing Consequences of Conflict-related Sexual Violence Among Women Living in Democratic Republic of Congo
1 other identifier
observational
742
1 country
1
Brief Summary
In conflict situations, sexual violence (SV) used can take various forms, including rape and female genital mutilation (FGM). SV is used as a strategic weapon to shake, terrorize, and displace communities and thus take control of a particular population or territory. For two decades, the Great Lakes region of Central Africa, which includes the eastern part of the Democratic Republic of the Congo (DRC), has experienced a high degree of instability due to various armed conflicts. The attacks on civilians are illustrated by SV. In 2011, studies in DRC estimated that 1 150 women are raped every day and that 30% of women have experienced conflict-related sexual violence (CRSV) over the past 16 years. In addition to physical suffering, survivors of CRSV must live with psychological consequences. Traumatic fistula, one of the most extreme consequences of SV, is well described in the literature, as its surgical management. In contrast, the literature and the government illustrate a lack of accurate data on the physical consequences such as pelvic dysfunction and psychologic disorders following these attacks. To be able to put in place adequate care, it is necessary to identify the conditions and needs of the victims.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2021
CompletedFirst Submitted
Initial submission to the registry
January 20, 2023
CompletedFirst Posted
Study publicly available on registry
February 16, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2025
CompletedFebruary 16, 2023
February 1, 2023
4 years
January 20, 2023
February 7, 2023
Conditions
Outcome Measures
Primary Outcomes (4)
Urinary aspects
Urinary aspects will be assessed by one questionnaire: International Consultation on Incontinence Questionnaire Female Lower Urinary Tract SymptomsModules (ICIQ-FLUTS)
At the test time
Sexual aspects
Sexual aspects will be assessed by one questionnaire: Female Sexual Function Index (FSFI)
At the test time
Pelvic and Perineal aspect
Pelvic and Perineal aspect will be assessed by clinical examination made by a women assistant of the research team, physiotherapist expert on pelvic floor field • Examen of observation: presence of scars, lesions, inflammation, type of FGM as described by WHO classification and types of scars during external exam; Perineal pain, intensity and localization with Haslam and Laycock ring of continence, pelvic floor muscle tone with the Reissing tone scale which have a good interrater reliability for intra-vaginal manual assessment of pubococcygeus tone for expert examinator. Laycock's power, endurance, repetitions, fast contractions, every contraction timed (PERFECT) scale will be used for pelvic floor muscle assessment. The PERFECT scheme has demonstrated good reliability and validity as an assessment tool. .
At the test time
Ano-rectal aspect
Two questionnaires will be used; one to assess anal incontinence (AI) and one for constipation * The St. Mark's Incontinence Score (SMIS) * The Knowles, Eccersley, Scott Symptom Score (KESS
At the test time
Secondary Outcomes (2)
Psychological aspect: will assessing with be PCL-5 questionnaire
At the test time
Quality of Life (QoL)
At the test time
Other Outcomes (1)
Sociodemographic characteristic data
At the test time
Study Arms (2)
women victims of CRSV
* Inclusion criteria: Women victims of CRSV living in the places of enrolment in RDC, aged over 18 years and giving their consent to participate to this study. * Exclusion criteria: Pregnant women and women under 18 years old.
women without a history of CRSV
* Inclusion criteria: women without a history of CRSV living in the places of enrolment in RDC, aged over 18 years and giving their consent to participate to this study. * Exclusion criteria: Pregnant women and women under 18 years old.
Eligibility Criteria
Women in RDC
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Bertuit Jeannelead
- University of Kinshasacollaborator
Study Sites (1)
Betty Miangindula
Kinshasa, Democratic Republic of the Congo
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 20, 2023
First Posted
February 16, 2023
Study Start
September 1, 2021
Primary Completion
September 1, 2025
Study Completion
September 1, 2025
Last Updated
February 16, 2023
Record last verified: 2023-02